Abstract
Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.
Jan Brandt, Hildrun Haibel, Jaqueline Reddig, Joachim Sieper and Jürgen Braun
The Journal of Rheumatology January 2002, 29 (1) 118-122;
Jan Brandt
Hildrun Haibel
Jaqueline Reddig
Joachim Sieper
In this issue
Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.
Jan Brandt, Hildrun Haibel, Jaqueline Reddig, Joachim Sieper, Jürgen Braun
The Journal of Rheumatology Jan 2002, 29 (1) 118-122;